Biomarkers in Kidney Disease

A biomarker is a substance introduced into an organism to assess organ function or various aspects of health. For instance, rubidium chloride is employed in isotopic labeling to assess the perfusion of the heart muscle. Alternatively, it can be a substance whose detection indicates a specific disease state; for example, the presence of an antibody may signify an infection. More specifically, a biomarker indicates a change in the expression or condition of a protein that is associated with the risk or progression of a disease, or the responsiveness of the disease to a given treatment. Biomarkers can be distinctive biological properties or molecules detectable and measurable in body parts such as blood or tissue. They may signify either normal or diseased processes in the body. Biomarkers can include specific cells, molecules, or genes, gene products, chemicals, or hormones. Complex organ functions or overall characteristic changes in biological systems can also serve as biomarkers.

  • Molecules
  • Isotopic labelling

Related Conference of Biomarkers in Kidney Disease

August 28-29, 2025

10th World Kidney Congress

London, UK
November 03-04, 2025

29th European Nephrology Conference

Rome, Italy
December 10-11, 2025

12th World Congress on Epidemiology & Public Health

Amsterdam, Netherlands
March 09-10, 2026

17th Nephrology,Renal Medicine & Renal Care

Dubai, UAE
March 26-27, 2026

22nd World Nephrology Conference

Amsterdam, Netherlands
June 29-30, 2026

18th World Nephrology Summit

Aix-en-Provence, France

Biomarkers in Kidney Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in